Genomic analysis of elephants, which also have a low cancer incidence, uncovered a high number of TP53 pseudogenes, and elephant cells displayed an enhanced TP53-dependent DNA damage response compared to human cells4,5. The gene discussed is TP53; the disease is cancer.